Ohzeki T - Search Results

1

Clinical efficacy of fluvoxamine and functional polymorphism in a serotonin transporter gene on childhood autism.

Sugie Y, Sugie H, Fukuda T, Ito M, Sasada Y, Nakabayashi M, Fukashiro K, Ohzeki T. Sugie Y, et al. Among authors: ohzeki t. J Autism Dev Disord. 2005 Jun;35(3):377-85. doi: 10.1007/s10803-005-3305-2. J Autism Dev Disord. 2005. PMID: 16119478 Clinical Trial.

2

[Serotonin 2A receptor gene polymorphism and clinical efficacy of fluvoxamine in children with autistic disorder].

Sugie Y, Sugie H, Fukuda T, Ito M, Ohzeki T. Sugie Y, et al. Among authors: ohzeki t. No To Hattatsu. 2003 Jan;35(1):23-8. No To Hattatsu. 2003. PMID: 12607287 Clinical Trial. Japanese.

3

[Studies on the adverse effects of fluvoxamine treatment in children with autistic disorder: correlation with genetic polymorphism in serotonin related genes].

Sugie Y, Sugie H, Fukuda T, Ito M, Ohzeki T. Sugie Y, et al. Among authors: ohzeki t. No To Hattatsu. 2003 May;35(3):233-7. No To Hattatsu. 2003. PMID: 12755054 Japanese.

4

[Evaluation of the 2nd to 4th digit ratio in the patients with autism].

Osawa J, Sugie H, Fukuda T, Ito M, Sugie Y, Ohzeki T. Osawa J, et al. Among authors: ohzeki t. No To Hattatsu. 2005 Sep;37(5):424-5. No To Hattatsu. 2005. PMID: 16164250 Japanese. No abstract available.

5

Clinical relevance of in vitro chemoresistance in childhood acute myeloid leukemia.

Yamada S, Hongo T, Okada S, Watanabe C, Fujii Y, Ohzeki T. Yamada S, et al. Among authors: ohzeki t. Leukemia. 2001 Dec;15(12):1892-7. doi: 10.1038/sj.leu.2402305. Leukemia. 2001. PMID: 11753610

6

Different responsiveness in body weight and hepatic 11beta-hydroxysteroid dehydrogenase (11beta-HSD) type 1 mrna to 11beta-HSD inhibition by glycyrrhetinic acid treatment in obese and lean zucker rats.

Li RS, Nakagawa Y, Nakanishi T, Fujisawa Y, Ohzeki T. Li RS, et al. Among authors: ohzeki t. Metabolism. 2004 May;53(5):600-6. doi: 10.1016/j.metabol.2003.11.010. Metabolism. 2004. PMID: 15131764

7

In vitro efficacy of l-asparaginase in childhood acute myeloid leukaemia.

Okada S, Hongo T, Yamada S, Watanabe C, Fujii Y, Ohzeki T, Horikoshi Y, Ito T, Yazaki M, Komada Y, Tawa A. Okada S, et al. Among authors: ohzeki t. Br J Haematol. 2003 Dec;123(5):802-9. doi: 10.1046/j.1365-2141.2003.04703.x. Br J Haematol. 2003. PMID: 14632770 Free article.

8

Low plasma levels of hemostatic proteins during the induction phase in children with acute lymphoblastic leukemia: A retrospective study by the JACLS. Japan Association of Childhood Leukemia Study.

Hongo T, Okada S, Ohzeki T, Ohta H, Nishimura S, Hamamoto K, Yagi K, Misu H, Eguchi N, Suzuki N, Horibe K, Ueda K. Hongo T, et al. Among authors: ohzeki t. Pediatr Int. 2002 Jun;44(3):293-9. doi: 10.1046/j.1442-200x.2002.01556.x. Pediatr Int. 2002. PMID: 11982900

9

Growth hormone inhibits the 11 beta-Hydroxysteroid dehydrogenase type 1 gene promoter activity via insulin-like growth factor I in HepG2 cells.

Li RS, Nakagawa Y, Liu YJ, Fujisawa Y, Sai S, Nakanishi T, Chapman KE, Seckl JR, Ohzeki T. Li RS, et al. Among authors: ohzeki t. Horm Metab Res. 2008 Apr;40(4):286-8. doi: 10.1055/s-2008-1058076. Horm Metab Res. 2008. PMID: 18548388 No abstract available.

10

Differential regulation of 11beta-hydroxysteroid dehydrogenase-1 by dexamethasone in glucocorticoid-sensitive and -resistant childhood lymphoblastic leukemia.

Sai S, Nakagawa Y, Sakaguchi K, Okada S, Takahashi H, Hongo T, Seckl JR, Chapman KE, Ohzeki T. Sai S, et al. Among authors: ohzeki t. Leuk Res. 2009 Dec;33(12):1696-8. doi: 10.1016/j.leukres.2009.04.016. Epub 2009 May 14. Leuk Res. 2009. PMID: 19446331

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters